BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37779396)

  • 1. Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency.
    Gozzetti A; Bacchiarri F; Raspadori D; Sicuranza A; Sammartano V; Bocchia M
    Rev Recent Clin Trials; 2023; 18(4):300-303. PubMed ID: 37779396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases.
    Hoffman MA
    Med Oncol; 2011 Dec; 28(4):1537-41. PubMed ID: 20509009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
    Saven A; Burian C; Koziol JA; Piro LD
    Blood; 1998 Sep; 92(6):1918-26. PubMed ID: 9731048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
    Goodman GR; Burian C; Koziol JA; Saven A
    J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56-Positive Acute Myeloid Leukemia Following Treatment of Hairy Cell Leukemia with Cladribine - Report of 2 Cases and Review of the Literature.
    Colovic N; Marisavljevic D; Kraguljac-Kurtovic N; Bogdanovic A; Gotic M
    Arch Iran Med; 2019 May; 22(5):269-271. PubMed ID: 31256601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report.
    Ecsiova D; Kamaradova K; Nova M; Hoffmann P; Rozsivalova P; Simkovic M; Zak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Dec; 167(4):385-389. PubMed ID: 35713332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine.
    Tombak A; Aygün S; Serinsöz E; Tiftik EN
    Korean J Intern Med; 2015 Sep; 30(5):739-41. PubMed ID: 26354071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful surgical resection of rectal cancer in a patient with relapsed hairy cell leukemia under interferon-α treatment].
    Oka T; Hirata H; Kitagawa T; Io K; Nagai K
    Rinsho Ketsueki; 2021; 62(12):1672-1677. PubMed ID: 35022335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.
    Nieva J; Bethel K; Saven A
    Blood; 2003 Aug; 102(3):810-3. PubMed ID: 12663446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis.
    Hilbe W; Berger T; Konwalinka G; Thaler J
    Acta Haematol; 1999; 102(2):99-100. PubMed ID: 10529514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hairy cell leukemia: therapeutic approaches].
    Paitel JF; Guerci A; Lederlin P
    Rev Med Interne; 1996; 17(5):399-406. PubMed ID: 8763100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
    Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disease with hope: hairy cell leukemia.
    Becker SE
    Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.